Tailored Drug Titration Through Artificial Intelligence

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 1, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

March 31, 2020

Conditions
Hypertension
Interventions
OTHER

optima4BP

optima4BP will provide the treating physician with a treatment action recommendation for consideration.

Trial Locations (1)

94123

University of California San Francisco, San Francisco

Sponsors
All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

Optima Integrated Health

INDUSTRY

NCT03397524 - Tailored Drug Titration Through Artificial Intelligence | Biotech Hunter | Biotech Hunter